doi: 10.1017/S0029665120000166
Based on market size data of these medications from different sources, we estimate that Ozempic has the largest market share globally with 31.93% and $16.9 billion USD, followed by Mounjaro with 18.46% and $9.8 billion USD
There is also evidence that GLP-1RA (such as Lira, etc.) can significantly reduce food intake and promote fatty acid oxidation, thus promoting weight loss and fat mass reduction [16,96]
"But microdosing has not been well studied in clinical trials, and most of the data is anecdotal." She said that when someone asks her about microdosing a GLP-1, she advises that, since it's off-label (meaning not approved by the FDA), carefully monitoring their blood sugar, weight, and symptoms is essential
While we observed changes in deoxycholic acid levels in plasma and fecal samples after liraglutide treatment, the clinical relevance remains unclear (93)
There is no legitimate way to get one without a licensed clinician evaluating you first
